Home Ingredients Fructan Hydrolase (FODMAP-Targeted)
Gut Health

Fructan Hydrolase (FODMAP-Targeted)

Fructan hydrolase / inulinase (EC 3.2.1.7)
Evidence Level
Limited
2 Clinical Trials
4 Documented Benefits
2/5 Evidence Score

Fructan hydrolase (also called inulinase) is a specialized enzyme that breaks down fructans — the primary FODMAP carbohydrate responsible for many IBS symptoms. Fructans are found in wheat, onions, garlic, leeks, asparagus, artichokes, and certain other plants. They are short-chain fructose polymers that humans cannot digest, causing bloating, gas, and abdominal pain in FODMAP-sensitive individuals (50–80% of IBS patients). Fructan hydrolase is the active enzyme in FODZYME® (the most-clinically-studied FODMAP-targeted enzyme), released in 2021. Allows FODMAP-sensitive individuals to enjoy fructan-containing foods without requiring strict low-FODMAP elimination.

Studied Dose FODZYME®-style products: 1 sprinkle/serving with FODMAP-containing meals
Active Compound Fructan hydrolase enzyme (typically Aspergillus niger-derived inulinase)

Benefits

Reduced FODMAP-induced symptoms in IBS

FODZYME® clinical trials demonstrate fructan hydrolase reduces hydrogen breath test elevation (a marker of bacterial fermentation in the colon) by 40–60% after FODMAP-rich meals in IBS patients. Subjects also report significantly reduced abdominal pain, bloating, and gas. While this is a newer intervention with smaller evidence base than older enzymes, the targeted mechanism (FODMAP-specific) makes it particularly valuable for IBS patients.

Supported by Trial 1

Practical alternative to strict low-FODMAP elimination

The low-FODMAP diet, while effective for IBS, is restrictive (eliminating wheat, garlic, onions, many fruits, dairy) and difficult to maintain long-term. Fructan hydrolase enables FODMAP-sensitive individuals to enjoy fructan-containing foods occasionally without triggering symptoms. This is a quality-of-life advantage particularly valuable in social/restaurant settings where FODMAP-free options may be limited.

Supported by Trial 2, Trial 1

Sparing of beneficial fructan effects (controlled bacterial fermentation)

Fructans are also beneficial prebiotics that feed gut bifidobacteria and lactobacilli. Strict elimination of all fructans deprives the gut microbiome of these beneficial substrates over time. Fructan hydrolase supplementation allows controlled, occasional fructan consumption (with reduced symptom burden) rather than complete elimination — preserving microbiome diversity over time.

Supported by Trial 2, Trial 1

Reduced anxiety and food restriction in IBS patients

Many IBS patients experience significant anxiety around food choices and social eating. Fructan hydrolase provides a 'safety net' that reduces fear of accidental FODMAP exposure, improving quality of life beyond direct symptom reduction. This psychological benefit is increasingly recognized as important in IBS management.

Supported by Trial 1, Trial 2

Mechanism of action

1

Hydrolysis of β-2,1 fructose-fructose bonds

Fructans are linear or branched chains of fructose units linked by β-2,1 glycosidic bonds (with a terminal glucose unit). Fructan hydrolase cleaves these bonds, breaking fructans into smaller fragments (oligofructose) and ultimately individual fructose units, which are absorbed in the small intestine via GLUT5 transporters. This prevents fructan from reaching the colon for bacterial fermentation — the cause of FODMAP-related bloating and gas.

2

FODMAP-targeted action with minimal effect on non-FODMAP nutrients

Fructan hydrolase is highly substrate-specific — it targets fructans and inulin without significantly affecting protein, fat, starch, or other dietary components. This focused mechanism means it doesn't 'over-digest' food in ways that could affect normal nutrition or beneficial fiber fermentation.

3

Stomach and small intestine activity

Aspergillus-derived fructan hydrolases are acid-stable and active across pH 3-7, allowing them to begin breaking down fructans immediately in the stomach and continue throughout the small intestine. This pre-empts colonic fructan delivery, where bacterial fermentation drives symptoms.

Clinical trials

1
FODZYME® for FODMAP-Sensitive IBS — Pilot Clinical Trial

Randomized, double-blind, placebo-controlled crossover pilot trial. IBS patients consumed FODMAP-rich meal (containing inulin/fructans) with FODZYME® enzyme blend (containing fructan hydrolase) or placebo, with hydrogen breath test measurement and subjective symptom scores. (2023 pilot clinical trial)

Pilot IBS sample.

Hydrogen breath test elevation reduced ~50% with enzyme. Subjective symptoms (bloating, gas, abdominal pain) significantly improved vs placebo for FODMAP-rich meal. Pilot data — full clinical efficacy needs larger replication. Promising for enabling dietary flexibility in IBS-FODMAP-sensitive patients.

2
FODMAP-Targeted Enzymes for IBS — Real-World Evidence

Observational and quasi-experimental studies of combined FODMAP-targeted enzyme blends (including fructan hydrolase, alpha-galactosidase, and lactase) in IBS patients. (2023 review)

Mixed observational evidence.

Patients using FODMAP-enzyme blends report meaningful symptom improvement with greater dietary flexibility than strict FODMAP elimination. However, evidence is preliminary; not all FODMAPs are equally enzyme-sensitive (polyols and fructose malabsorption are not addressed by these enzymes). Best as adjunct to dietitian-guided low-FODMAP approach, not replacement.

Side effects and drug interactions

Common Potential side effects

Generally extremely well-tolerated; newer enzyme with limited long-term safety data but no serious concerns
Allergic reactions to fungal source in sensitized individuals
Not a replacement for proper medical evaluation of IBS — should complement, not replace, gastroenterologist-supervised care

Important Drug interactions

No known significant drug interactions
Compatible with other digestive enzymes and supplements
Does not affect medication absorption

More Gut Health Ingredients

Metabolic Health
Psyllium Husk (Plantago ovata)
Psyllium husk is the soluble fiber derived from the seed husks of Plantago ovata — the mos…
Gut Health
Pancrelipase / Pancreatin
Pancrelipase (also called pancreatin) is a standardized blend of three primary pancreatic…
Gut Health
Sunfiber® (Partially Hydrolyzed Guar Gum)
Sunfiber® is the original and most extensively clinically-studied partially hydrolyzed gua…
Immune Support
EpiCor® (Postbiotic Yeast Fermentate — Cargill)
EpiCor® is a postbiotic ingredient from Cargill — derived from the fermentation of Sacchar…

Explore Other Ingredients

Muscle & Recovery
L-Glutamine
L-glutamine is the most abundant amino acid in the body and the primary metabolic fuel for…
Antioxidant
Chlorella
Chlorella is a single-celled freshwater green algae rich in chlorophyll, complete protein…
Metabolic Health
Inulin
Inulin is a soluble prebiotic fiber found naturally in chicory root, agave, and many veget…

Frequently asked questions about Fructan Hydrolase (FODMAP-Targeted)

What is fructan-hydrolase?

Fructan-hydrolase enzymes break down fructans, a type of fermentable carbohydrate (a FODMAP) found in wheat, onions, garlic, and some vegetables. They help people sensitive to fructans digest them with less gas and bloating.

Do fructan enzymes help with FODMAP sensitivity or IBS?

These enzymes are marketed to help break down fructans before they reach the colon, potentially easing the gas, bloating, and discomfort some people with IBS or FODMAP sensitivity get from foods like onion, garlic, and wheat. Individual results vary.

When should I take fructan-hydrolase?

Take it at the start of meals containing fructan-rich foods (wheat, onion, garlic, certain vegetables) so the enzyme can act as you digest.

Is fructan-hydrolase safe?

As a digestive enzyme it is generally well tolerated. It is a tool for symptom comfort, not a cure for IBS, so a broader gut-health approach is still wise. Check with your doctor if you have a digestive condition.

What is Fructan Hydrolase?

Fructan hydrolase (also called inulinase) is a specialized enzyme that breaks down fructans — the primary Fodmap carbohydrate responsible for many IBS symptoms. Fructans are found in wheat, onions, garlic, leeks, asparagus, artichokes, and certain other plants.

What is Fructan Hydrolase used for?

Fructan Hydrolase is researched primarily for Gut Health. Fodzyme® clinical trials demonstrate fructan hydrolase reduces hydrogen breath test elevation (a marker of bacterial fermentation in the colon) by 40–60% after Fodmap-rich meals in IBS patients.

What is the recommended dosage of Fructan Hydrolase?

The clinically studied dose is Fodzyme®-style products: 1 sprinkle/serving with Fodmap-containing meals Always follow the product label and check with a healthcare provider for personal advice.

Is Fructan Hydrolase safe, and does it have side effects?

For most healthy adults, Fructan Hydrolase is well tolerated at studied doses. Reported effects can include: Generally extremely well-tolerated; newer enzyme with limited long-term safety data but no serious concerns Allergic reactions to fungal source in sensitized individuals It may also interact with some medications. Fructan Hydrolase is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Fructan Hydrolase interact with any medications?

Possible interactions include: No known significant drug interactions Compatible with other digestive enzymes and supplements If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Fructan Hydrolase?

NutraSmarts rates the evidence for Fructan Hydrolase as Limited (2 out of 5). It is backed by 2 clinical trials and 2 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(2 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Guice JL, Hollins MD, Farmar JG, Tinker KM, Garvey SM Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions Frontiers in Nutrition. 2023;10:1129329. doi: 10.3389/fnut.2023.1129329.PubMedUsed to support: Demonstrates that microbial inulinase (fructan hydrolase) effectively breaks down fructans under conditions simulating the human gastric environment. Directly supports the enzyme's mechanism of action for reducing FODMAP-induced symptoms by pre-digesting fructans before intestinal exposure. In-vitro/simulated GI model, not a human clinical trial.
  2. Ochoa KC, Samant S, Liu A In Vitro Efficacy of Targeted Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Enzymatic Digestion in a High-Fidelity Simulated Gastrointestinal Environment Gastro Hep Advances. 2023;2(3):283-290..PubMedUsed to support: In-vitro study demonstrating targeted enzymatic digestion of FODMAPs (including fructans) in a high-fidelity simulated GI environment. Supports the fructan hydrolase mechanism for reducing FODMAP load before intestinal fermentation — the basis for IBS symptom relief. Not a human clinical trial.